Deborah Dunsire Insider Trading $RARE Ultragenyx Pharmaceutical Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Deborah Dunsire.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Deborah Dunsire. Deborah Dunsire is Director in ALLERGAN INC ($AGN) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and President and CEO in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and President, CEO in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in Ultragenyx Pharmaceutical Inc. ($RARE).
Deborah Dunsire in Ultragenyx Pharmaceutical Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Deborah Dunsire: Director
Holdings: 10,425 shares
Current Value: $760,087
Latest Transaction: Jun 30 2020
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Deborah Dunsire in Ultragenyx Pharmaceutical Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, AGN, MLNM, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 | |
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 2,550 | 0 | 10,425 | 7.9 K to 10.4 K (+32.38 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 3,000 | 0 | 7,875 | 4.9 K to 7.9 K (+61.54 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 3,000 | 0 | 4,875 | 1.9 K to 4.9 K (+160.00 %) |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K |
| Apr 10 2017 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 58.59 | 15,000 | 878,850 | 15,000 |
Page: 1